Table of Contents How Retatrutide May Affect Blood Pressure Evidence From Clinical Trials on Cardiovascular Outcomes Who Should Exercise Caution With This Treatment Monitoring Blood Pressure During Retatrutide Therapy Interactions With Antihypertensive Medicines Current MHRA and NICE Guidance on Use in the UK Scientific References Frequently Asked Questions How Retatrutide May Affect Blood Pressure Retatrutide has been associated with modest blood pressure reductions in Phase 2 trials, most likely driven by weight loss-mediated decreases in vascular resistance, with additional contributions from possible natriuretic and endothelial effects extrapolated from the GLP-1 drug class
These drugs, such as semaglutide, liraglutide etc., mimic the effects of a natural hormone (GLP-1 hormone) produced by the body, such as reducing appetite, improving insulin activity and supporting metabolism 1
RYBELSUS (formulation R2)(2.3) Day 1 to 30: Recommended starting dosage is 1.5 mg orally once daily for 30 days (this dosage is not effective for glycemic control)
However, clinicians should maintain heightened awareness and conduct thorough risk assessment
What's next for the peptide ruling
Chalcones and their derivatives demonstrate a wide range of biological activities including anti-inflammation (Mahapatra et al
